Verbeke, K., T. Krawczyk, D. Baeyens, J. Piasecki, and P. Borry, “What’s in a Lie? How Researchers Judge the Justifiability of Deception,” Ethics & Human Research 47, no. 3 (2025): 13-29, tables. DOI: 10.1002/eahr.60003

Nellis, K. L., R. Lichtman, J. Birnbaum, S. Friedman, and E. Zwicklbauer, “Incorporating Gender-Neutral Language in IRB Materials: Perceptions of IRB Professionals,” Ethics & Human Research 47, no. 3 (2025): 30-39, Appendix, Appendix_B, Appendix_C, Figures_and_tables. DOI: 10.1002/eahr.60022

Speight, C. D., O. M. Adeoye, S. I. Davis, M. J. Linke, A. R. Mitchell, and N. W. Dickert, “Stakeholder Views on Novel Consent Forms for an Acute Stroke Trial,” Ethics & Human Research 47, no. 2 (2025): 16-25. tables 1 and 2 DOI: 10.1002/eahr.600010

Bosack, E., D. Bourne, E. Epstein, M. F. Marshall, and D. T. Chen, “Investigating Moral Distress in Clinical Research Professionals—A Deep Dive into Troubled Waters,” Ethics & Human Research 47, no. 1 (2025): 34-45, table 2. DOI:10.1002/eahr.60003

Shah, S. K., A. Ibrahim, A. Hinga, D. Vintimilla, M. Jones, A. Rid, L. Eckstein, and D. Kamuya, “Ethical Issues Faced by Data Monitoring Committees: Results from an Exploratory Qualitative Study,” Ethics & Human Research 46, no. 6 (2024): 2-13, appendix 1, appendix 2, appendix 3. DOI: 10.1002/eahr.500227

Waltz, A., B. Johnson, and P. H. Schwartz, “Clarifying and Limiting Responsibilities: Guidelines for Investigators and the IRB on Return of Clinically Relevant Research Results to Participants,” Ethics & Human Research 46, no. 2 (2024): 22-29, appendix. DOI: 10.1002/eahr.500204

Guetterman, T. C., A. Haggins, S. Montas, J. Black, D. Harney, M. D. Fetters, R. Silbergleit, and N. W. Dickert, “Institutional Review Boards’ Assessment of Local Context: A Mixed Methods Study,” Ethics & Human Research 46, no. 1 (2024): 2-13, appendix. DOI: 10.1002/eahr.500195

Spahnie, M., A. Matthews, D. Kiss, J. Ricks, W. Miller, and A. N. Turner, “Positive and Negative Social Consequences of Participating in a Sexual-Network Study,” Ethics & Human Research 46, no. 1 (2024): 14-25, figures. DOI: 10.1002/eahr.500196

Chongwe, G., J. Ali, D. K. Kaye, C. Michelo, and N. E. Kass, “Ethics of Adaptive Designs for Randomized Controlled Trials,” Ethics & Human Research 45, no. 5 (2023): 2-14, appendices. DOI: 10.1002/eahr.500178

Corneli, A., K. McKenna, E. Hanlen-Rosado, S. B. Calvert, E. Mah, and S. J. Rosenfeld, “Stakeholder Reflections on Implementing the National Institutes of Health’s Policy on Single Institutional Review Boards,” Ethics & Human Research 45, no. 5 (2023): 15-26, tables. DOI: 10.1002/eahr.500179

Rennie, S., G. Henderson, N. Phanuphak, K. Kuczynski, D. Colby, N. Ormsby, E. Kroon, D. Hsu, U. Likhitwonnawut, S. Vasan, C. Sacdalan, T. Jupimai, O. Butterworth, and H. Peay, “The Essential Need for Trust When Transmission Risk Cannot Be Eliminated in HIV-Remission Trials,” Ethics & Human Research 45, no. 4 (2023): 2-15, appendix. DOI: 10.1002/eahr.500172

Ries, N. M., and B. Johnston, “Making an Advance Research Directive: An Interview Study with Adults Aged 55 and Older with Interests in Dementia Research,” Ethics & Human Research 45, no. 3 (2023): 2-17, appendix A, appendix B. DOI: 10.1002/eahr.500171

Tackett, S., C. J. Ng, J. Sugarman, E. G. S. Daniel, N. Gopalan, Tivyashinee, A. Kamarulzaman, and J. Ali, “A Competency Framework for Health Research Ethics Educational Programs: Results from a Stakeholder-Driven Mixed-Method Process,” Ethics & Human Research 45, no. 3 (2023): 29-39, figure 1, appendix A,  appendix B. DOI: 10.1002/eahr.500166

Gottula, A. L., S. Constand, S. Cabrera, U. Stolz, A. Salvator, M. Goodman, and J. McMullan, “Remnant Blood Quantification: Informing the Definition of Minimal Risk in Clinical Research,” Ethics & Human Research 45, no. 2 (2023): 35-39, appendices. DOI: 10.1002/eahr.500160

Harrison, R., “Legally Effective but Ethically Inadequate: Institutional Review Board Policies for Consent from Legally Authorized Representatives,” Ethics & Human Research 45, no. 2 (2023): 14-25, tables. DOI: 10.1002/eahr.500158

Guttmann, K. F., S. Li, Y. W. Wu, S. E. Juul, B. S. Wilfond, and E. M. Weiss, on behalf of the HEAL Recruitment Collaborative, “Factors That Impact Hospital-Specific Enrollment Rates for a Neonatal Clinical Trial: An Analysis of the HEAL Study,” Ethics & Human Research 45, no. 1 (2023): 29-38, appendix. DOI: 10.1002/eahr.500154

Walker, R. L., D. MacKay, M. Waltz, A. D. Lyerly, and J. A. Fisher, “Ethical Criteria for Improved Human Subject Protections in Phase I Healthy Volunteer Trials,” Ethics & Human Research 44, no. 5 (2022): 2-21, appendix, DOI: 10.1002/eahr.500139

Kim, J. P., S. Mondal, T. Tsungmey, K. Ryan, L. B. Dunn, and L. W. Roberts, “Influence of Dispositional Optimism on Ethically Salient Research Perspectives: A Pilot Study,” Ethics & Human Research 44, no. 3 (2022): 12-23, appendix. DOI: 10.1002/eahr.500126

Matera-Vatnick, M., K. W. Todman, P. G. Wakim, H. K. Sullivan, C. Squires, J. Brintnall-Karabelas, S. N. Doernberg, and M. Danis, “Evaluating the Ability to Consent to Research: A Twenty-Year Track Record,” Ethics & Human Research 44, no. 2 (2022): 2-17, figure. DOI: 10.1002/eahr.500119

Campbell, G., M. D. Dixon, M. Lohani, J. Cook, R. Hianik, M. C. Thomson, E. Abernethy, C. Lewis, J. Switchenko, R. D. Harvey, and R. D. Pentz, “Therapeutic Misconception about Research Procedures: Does a Simple Information Chart Improve Understanding?,” Ethics & Human Research 44, no. 2 (2022): 18-25, “Interview Questions Assessing Understanding of Non-Therapeutic Procedures” and two sample information-chart drafts. DOI: 10.1002/eahr.500120

Serpico, K., V. Rahimzadeh, E. E. Anderson, L. Gelinas, and H. F. Lynch, “Institutional Review Board Use of Outside Experts: What Do We Know?,” Ethics & Human Research 44, no. 2 (2022): 26-32, two appendices. DOI: 10.1002/eahr.500121

Trahan, M-J., A. Cumyn, M. P. Cheng, E. G. McDonald, S. E. Lapinsky, N. Daneman, H. A. Abenhaim, and I. Malhamé, “Physician Perspectives on Including Pregnant Women in Covid-19 Clinical Trials: Time for a Paradigm Change,” Ethics & Human Research 44, no. 6 (2021): 19-27, tables and appendices. DOI: 10.1002/eahr.500107

Johnson, A. R., L. M. Rigtrup, J. VanBuren, E. Rothwell, and J. M. Dean, “An Approach to Reviewing Local Context for Exception from Informed Consent Trials Using a Single IRB,” Ethics & Human Research 43, no. 6 (2021): 42-48, appendices. DOI: 10.1002/eahr.500109

Vigil, D., N. Sinaii, and B. Karp, “American Indian and Alaska Native Enrollment in Clinical Studies in the National Institutes of Health’s Intramural Research Program,” Ethics & Human Research 43, no. 3 (2021): 2-9, tables and figures. DOI: 10.1002/eahr.500090

Ries, N., and E. Mansfield, “Advance Research Directives: Dementia Researchers’ Views on a Prototype Directive and Implementation Strategies,” Ethics & Human Research 43, no. 3 (2021): 10-25, appendix. DOI: 10.1002/eahr.500091

Corneli, A., C. B. Dombeck, K. McKenna, and S. B. Calvert, “Stakeholder Experiences with the Single IRB Review Process and Recommendations for Food and Drug Administration Guidance,” Ethics & Human Research 43, no. 3 (2021): 26-36, tables and appendix. DOI: 10.1002/eahr.500092

Barnes, M., J. Carrithers, and J. Sugarman, “Ethical and Practical Concerns about IRB Restrictions on the Use of Research Data,” Ethics & Human Research 42, no. 6 (2020): 29-34, table. DOI: 10.1002/eahr.500072

Beskow, L. M., C. M. Hammack-Aviran, and K. M. Brelsford, “Thought Leader Comparisons of Risks in Precision Medicine Research,” Ethics & Human Research 42, no. 6 (2020): 35-40, table, box, figures, appendix. DOI: 10.1002/eahr.500059

Ferretti, A., et al., “Big Data, Biomedical Research, and Ethics Review: New Challenges for IRBs,” Ethics & Human Research 42, no. 5 (2020): 17-28,  figures and appendices. DOI: 10.1002/eahr.500065

Roberts, M. K., et al., “Ethical and Regulatory Concerns in Pragmatic Clinical Trial Monitoring and Oversight,” Ethics & Human Research 42, no. 5 (2020): 29-37, tables and figure. DOI: 10.1002/eahr.500066

Mastroianni, A. C., et al., “The Pathway Forward: Insights on Factors that Facilitate Research with Pregnant Women,” Ethics & Human Research 42, no. 4 (2020): 2-16, figure. DOI: 10.1002/eahr.500058

McMillan, G., “IRB Policies for Obtaining Informed Consent from Non-English-Speaking People,” Ethics & Human Research 42, no. 3 (2020): 21-29, tables. DOI: 10.1002/eahr.500050

Paquette, E. T., H. Palac, E. Bair, B. Schultz, N. Stenquist, A. Shukla, and S. Joffe, “The Importance of Engaging Children in Research Decision-Making: A Preliminary Mixed-Methods Study,” Ethics & Human Research 42, no. 3 (2020): 12-20, tables, figures, appendix. DOI: 10.1002/eahr.500049

Lasser, J., et al., “Contemporary College Students’ Attitudes about Deception in Research,” Ethics & Human Research 42, no. 1 (2020): 14-21, appendix. DOI: 10.1002/eahr.500039

Klitzman, R., et al., “When IRBs Say No to Participating in Research about Single IRBs,” Ethics & Human Research 42, no. 1 (2020): 36-40, table S1. DOI: 10.1002/eahr.500041

Rostami, M., et al., “Safeguarding Participants in Psychiatric Genetic Research: Perspectives of Key Stakeholder Groups,” Ethics & Human Research 41, no. 6 (2019): 12-22, tables; figures; appendix. DOI: 10.1002/eahr.500034

Kratka, A., et al., “HIV Cure Research: Risks Patients Expressed Willingness to Accept,” Ethics & Human Research 41, no. 6 (2019): 23-34, tables S1 and S2. DOI: 10.1002/eahr.500035

Brelsford, K. M., et al., “Improving Translation and Cultural Appropriateness of Spanish-Language Consent Materials for Biobanks,” Ethics & Human Research 41, no. 5 (2019): 16-27, tables 1-4; Spanish-language consent materials. DOI: 10.1002/eahr.500028

Sugarman, J., et al., “Reported Participation Benefits in International HIV Prevention Research with People Who Inject Drugs,” Ethics & Human Research 41, no. 5 (2019): 28-34, table 1; appendix. DOI: 10.1002/eahr.500030

Binik, Ariella, and Hey, Spencer Philips, “A Framework for Assessing Scientific Merit in Ethical Review of Clinical Research,” Ethics & Human Research 41, no. 2 (2019): 2-13, figure S1. DOI: 10.1002/eahr.500007